Wai Liu

Person

London, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Cancer treatment
- Patent number 12,324,805
- Issue date Jun 10, 2025
- LDN PHARMA LIMITED
- Wai Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination of cannabinoids in the treatment of leukemia
- Patent number 12,161,607
- Issue date Dec 10, 2024
- Jazz Pharmaceuticals Research UK Limited
- Stephen Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Priming of cancer cells with low dose naltrexone
- Patent number 12,144,807
- Issue date Nov 19, 2024
- LDN PHARMA LIMITED
- Angus Dalgleish
- G01 - MEASURING TESTING
Information Patent Grant
Autoimmune therapy
- Patent number 12,029,737
- Issue date Jul 9, 2024
- LDN PHARMA LIMITED
- Wai Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination of a cannabinoid and a chemotheraopeutic agent for the...
- Patent number 11,607,423
- Issue date Mar 21, 2023
- Akos Biosciences, Inc.
- Angus Dalgleish
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Priming of cancer cells with low dose naltrexone
- Patent number 11,065,245
- Issue date Jul 20, 2021
- Cancer Vaccine Institute
- Angus Dalgleish
- G01 - MEASURING TESTING
Information Patent Grant
Combination of cannabinoids in the treatment of leukaemia
- Patent number 11,000,486
- Issue date May 11, 2021
- GW Research Limited
- Stephen Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of tetrahydrocannabinol and/or cannabidiol for increasing radio...
- Patent number 10,758,514
- Issue date Sep 1, 2020
- GW Pharma Limited
- Wai Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating cancer using a combination of an immunomodulato...
- Patent number 9,226,913
- Issue date Jan 5, 2016
- Celgene Corporation
- Angus Dalgleish
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
PRIMING OF CANCER CELLS WITH LOW DOSE NALTREXONE
- Publication number 20250032481
- Publication date Jan 30, 2025
- LDN Pharma Limited
- Angus Dalgleish
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NALTREXONE FOR IMPROVING THE EFFECTIVENESS OF 5-HT RECEPTOR SUBTYPE...
- Publication number 20240293395
- Publication date Sep 5, 2024
- LDN Pharma Limited
- Wai Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS COMPRISING AN AGONIST OF 5-HYDROXYTRYPTAMINE (5-HT) RE...
- Publication number 20240285612
- Publication date Aug 29, 2024
- LDN Pharma Limited
- Wai Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT FOR AUTOIMMUNE DISEASES
- Publication number 20240285613
- Publication date Aug 29, 2024
- LDN Pharma Limited
- Wai Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AUTOIMMUNE THERAPY
- Publication number 20230381171
- Publication date Nov 30, 2023
- LDN Pharma Limited
- Wai Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ADMINISTRATION REGIMES OF CANNABINOIDS IN COMBINATION WITH CHEMOTHE...
- Publication number 20220362168
- Publication date Nov 17, 2022
- Jay Pharma Inc.
- Wai Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR DETERMINING EFFICACY
- Publication number 20220196659
- Publication date Jun 23, 2022
- LDN Pharma Limited
- Wai Liu
- G01 - MEASURING TESTING
Information Patent Application
CANCER TREATMENT COMPRISING NALTREXONE AND A CANNABINOID
- Publication number 20220143010
- Publication date May 12, 2022
- LDN Pharma Limited
- Wai Liu
- G01 - MEASURING TESTING
Information Patent Application
PRIMING OF CANCER CELLS WITH LOW DOSE NALTREXONE
- Publication number 20210308125
- Publication date Oct 7, 2021
- CANCER VACCINE INSTITUTE
- Angus Dalgleish
- G01 - MEASURING TESTING
Information Patent Application
COMBINATION OF CANNABINOIDS IN THE TREATMENT OF LEUKAEMIA
- Publication number 20210308072
- Publication date Oct 7, 2021
- GW Research Limited
- Stephen Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AUTOIMMUNE THERAPY
- Publication number 20210052574
- Publication date Feb 25, 2021
- LDN Pharma Limited
- Wai Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF A CANNABINOID AND A CHEMOTHERAOPEUTIC AGENT FOR THE...
- Publication number 20210030779
- Publication date Feb 4, 2021
- Jay Pharma Inc.
- Angus Dalgleish
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF CANNABINOIDS IN THE TREATMENT OF LEUKAEMIA
- Publication number 20200022925
- Publication date Jan 23, 2020
- GW Research Limited
- Stephen Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF TETRAHYDROCANNABINOL AND/OR CANNABIDIOL FOR INCREASING RADIO...
- Publication number 20190099398
- Publication date Apr 4, 2019
- GW Pharma Limited
- Wai LIU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PRIMING OF CANCER CELLS WITH LOW DOSE NALTREXONE
- Publication number 20170119755
- Publication date May 4, 2017
- CANCER VACCINE INSTITUTE
- Angus Dalgleish
- G01 - MEASURING TESTING
Information Patent Application
USE OF TETRAHYDROCANNABINOL AND/OR CANNABIDIOL FOR INCREASING RADIO...
- Publication number 20160136127
- Publication date May 19, 2016
- GW Pharma Limited
- Wai LIU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING CANCER USING A COMBINATION OF AN IMMUNOMODULATO...
- Publication number 20130136757
- Publication date May 30, 2013
- Angus Dalgleish
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

Cancer treatment

Combination of cannabinoids in the treatment of leukemia

Priming of cancer cells with low dose naltrexone

Autoimmune therapy

Combination of a cannabinoid and a chemotheraopeutic agent for the...

Priming of cancer cells with low dose naltrexone

Combination of cannabinoids in the treatment of leukaemia

Use of tetrahydrocannabinol and/or cannabidiol for increasing radio...

Methods of treating cancer using a combination of an immunomodulato...

Patents Applicationslast 30 patents

PRIMING OF CANCER CELLS WITH LOW DOSE NALTREXONE

NALTREXONE FOR IMPROVING THE EFFECTIVENESS OF 5-HT RECEPTOR SUBTYPE...

COMPOSITIONS COMPRISING AN AGONIST OF 5-HYDROXYTRYPTAMINE (5-HT) RE...

TREATMENT FOR AUTOIMMUNE DISEASES

AUTOIMMUNE THERAPY

ADMINISTRATION REGIMES OF CANNABINOIDS IN COMBINATION WITH CHEMOTHE...

METHOD FOR DETERMINING EFFICACY

CANCER TREATMENT COMPRISING NALTREXONE AND A CANNABINOID

PRIMING OF CANCER CELLS WITH LOW DOSE NALTREXONE

COMBINATION OF CANNABINOIDS IN THE TREATMENT OF LEUKAEMIA

AUTOIMMUNE THERAPY

COMBINATION OF A CANNABINOID AND A CHEMOTHERAOPEUTIC AGENT FOR THE...

COMBINATION OF CANNABINOIDS IN THE TREATMENT OF LEUKAEMIA

USE OF TETRAHYDROCANNABINOL AND/OR CANNABIDIOL FOR INCREASING RADIO...

PRIMING OF CANCER CELLS WITH LOW DOSE NALTREXONE

USE OF TETRAHYDROCANNABINOL AND/OR CANNABIDIOL FOR INCREASING RADIO...

METHODS OF TREATING CANCER USING A COMBINATION OF AN IMMUNOMODULATO...